RCUS · ISSUER CIK 1724521
Arcus Biosciences, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Arcus Biosciences, Inc. insiders reported $0.00 of open-market purchases and $85K of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 1 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$85KInsider selling
−$85KNet open-market
Aug 24, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 202617:52 | Aug 21, 2026 | RCUS | Chief Accounting Officer | S · Sell10b5-1 | $30.00 | −2,827 | 39,581 | -7% | −$85K | ||
| Aug 24, 202617:52 | Aug 21, 2026 | RCUS | Chief Accounting Officer | M · Exercise10b5-1 | $15.44 | +2,827 | 42,408 | +7% | $44K |